ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Cancer Risk and Incidence in Beckwith-Wiedemann Syndrome | Children’s Hospital of Philadelphia / Jennifer Kalish, MD/PhD | Epidemiology Grants | 2019 | Pennsylvania |
Targeting MYCN | Children’s Hospital of Philadelphia / Yael Mossé, MD & Julie Park, MD | Crazy 8 Pilots | 2019 | Pennsylvania |
Preclinical Development of Targeted Therapy for Neuroblastoma with ALK and CDK4/6 Dual Pathway Inhibition | Children’s Hospital of Philadelphia / Yael Mossé, MD | Reach Grants | 2013 | Pennsylvania |
Biology-based clinical trials for children with cancer. | Children’s Hospital of Philadelphia / Rochelle Bagatell | Phase I/II Infrastructure Grants | 2009 | Pennsylvania |
Alex's Lemonade Stand Foundation Center of Excellence in Childhood Cancer Drug Development and Clinical Pharmacology at The Children's Hospital of Philadelphia | Children’s Hospital of Philadelphia / Frank Balis, MD - Scholar: Emily Blauel, MD | Center of Excellence Grants | 2013 | Pennsylvania |
BH3 Profiling to define therapy resistance classes in neuroblastoma | Children’s Hospital of Philadelphia / Michael Hogarty, MD | Innovation Grants | 2011 | Pennsylvania |
Variation in Care and Outcomes in Pediatric Acute Leukemia | Children’s Hospital of Philadelphia / Amanda DiNofia, MD | Young Investigator Grants | 2016 | Pennsylvania |
Drugging MYCN | Children’s Hospital of Philadelphia / Yael Mossé, MD | Crazy 8 Awards | 2020 | Pennsylvania |
GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma | Children’s Hospital of Philadelphia / Kristopher Bosse, MD | Young Investigator Grants | 2016 | Pennsylvania |
CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL | Children’s Hospital of Philadelphia / Asen Bagashev, PhD | Young Investigator Grants | 2016 | Pennsylvania |